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ABSTRACT 
Background: Our aim was to assess resting cerebral blood flow (rCBF) in children and adults 
with Autism Spectrum Disorder (ASD). Methods: We acquired pulsed arterial spin labeling 
MRI data in 44 generally high functioning ASD simplex participants and 66 typically developing 
(TD) controls with comparable mean full-scale IQ’s. We compared rCBF values voxel-wise 
across diagnostic groups and assessed correlations with symptom scores. We also assessed the 
moderating influences of participant age, sex, and IQ on our findings and the correlations of 
rCBF with NAA (N-acetylaspartate) metabolite levels. Results: We detected significantly higher 
rCBF values throughout frontal white matter and subcortical gray in ASD participants. rCBF 
correlated positively with socialization deficits in regions where ASD hyperperfusion was 
greatest. rCBF declined with increasing IQ in the TD group, a correlation that was absent in ASD 
participants because their rCBF values were elevated across all IQ levels. rCBF in the ASD 
group correlated inversely with NAA metabolite levels throughout frontal white matter, with 
greater rCBF accompanying lower and increasingly abnormal NAA levels relative to TD 
controls. Conclusions: These findings taken together suggest the presence of altered 
metabolism, likely of mitochondrial origin, and dysfunctional maintenance processes that 
support axonal functioning in ASD. These disturbances in turn likely reduce neural efficiency for 
cognitive and social functioning, and trigger compensatory responses from supporting glial cells, 
which subsequently increase rCBF to affected white matter. These findings, if confirmed, 
suggest cellular and molecular targets for novel therapeutics that address axonal pathology and 
bolster glial compensatory responses in ASD. 
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INTRODUCTION 
Regional cerebral blood flow (rCBF) is a surrogate measure of brain metabolism, because 
blood flow and metabolism are usually tightly coupled(1-5). Arterial Spin Labeling (ASL) 
provides absolute and reproducible measures of rCBF(6, 7) by magnetically labeling water in 
arterial blood as a diffusible tracer, analogous to the use of 15O water in PET scanning(8). Unlike 
PET, ASL does not require the use of a radioactive tracer and therefore can be used in children, 
and it is a less costly and procedurally less complicated set of procedures. Moreover, because 
perfusion signals are obtained by pair-wise subtraction of adjacently acquired tagged and control 
images, ASL is less prone to motion artifact, low frequency physiological noise, and baseline 
drift than more conventional BOLD-based functional imaging(9). Finally, perfusion maps 
quantify rCBF at every voxel in the brain, whereas task-based BOLD imaging quantifies neural 
activity only in locations that the task activates, often confounded by systematic biases in task 
performance across participants(10). 
We are aware of only one previous preliminary study employing ASL in persons with 
Autism Spectrum Disorder (ASD) and typically developing (TD) controls, which had a limited 
sample size, included only children, and reported abnormalities (increased rCBF) only in cortical 
gray matter of the ASD group(11). PET metabolism studies and SPECT rCBF studies in ASD 
have had small numbers of participants, and some have either employed sedation or compared 
against atypically developing patient controls; most have interrogated only gray matter, and their 
findings have been rather inconsistent. Nevertheless, FDG PET studies generally have reported 
reduced metabolism in cortical gray matter (anterior cingulate, parietal(12, 13), and temporal(14-
16) cortex) and increased metabolism in occipital(17, 18) and other cortical regions(19). One 
preliminary PET study reported hyperperfusion of basal ganglia and posterior cingulate cortex in 
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ASD(20), whereas larger 18FDG PET studies have found reduced basal ganglia and thalamus 
metabolism(21, 22). One FDG PET study assessed white matter metabolism explicitly, reporting 
higher metabolic rates that were greatest in prefrontal regions and internal capsule in 25 ASD 
compared with 55 TD adults during a verbal learning task(23). SPECT blood flow studies have 
generally reported reduced rCBF in temporal(24-31), parietal(25, 30, 31), and frontal(26, 27, 29-
33) cortices and basal ganglia(28, 31, 33). Prior resting state functional MRI (fMR ) studies have 
generally reported long-range underconnectivity and local overconnectivity(34-45), suggesting 
the presence of axonal pathology in ASD. 
We aimed to exploit some of the advantages of ASL to compare rCBF across a large 
sample of children and adults with ASD and age-, sex-, and IQ-matched TD controls. We also 
assessed the voxel-wise associations of ASL-based measures of rCBF and brain metabolism with 
MR spectroscopy-based measures of NAA (N-acetylaspartate)(46, 47) to understand how rCBF 
associates with this index of mitochondrial functioning(48-50), cellular metabolism(51), and 
neuronal abundance and viability(49, 50). Based on the prior metabolism and blood flow 
findings in ASD, we hypothesized a priori that we would detect reduced cortical and increased 
white matter rCBF. We also assessed the moderating effects of age, sex, and IQ on rCBF values 
in an effort to use rCBF values to parse the phenotypic heterogeneity of ASD. Finally, we 
assessed the voxel-wise correlation of rCBF with measures of NAA in ASD participants. 
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METHODS 
Sample Ascertainment & Characterization  
This was a subset of 110 participants(44 ASD,66 TD) drawn from a larger MRI study of 
200 ASD (simplex cases) and TD controls(36, 46); the ASL pulse sequence was not available for 
the earliest recruited participants in the larger study. ASD participants were recruited through the 
Developmental Neuropsychiatry Clinic at Columbia University and community awareness 
events. Because screening of participants occurred prior to the publication of DSM 5 diagnostic 
criteria for ASD, screening was based on DSM-IV-TR criteria for PDD. Potential participants 
were required to have a previous clinical DSM-IV-TR(52) diagnosis of Pervasive Developmental 
Disorder (PDD) and a score >15 on either the Social Communication Questionnaire Lifetime 
Version(53) or Autism-spectrum Quotient(54). Exclusion criteria specific to ASD were known 
medical conditions associated with autism (e.g., Fragile-X syndrome, tuberous sclerosis). The 
final consensus diagnoses were established by a physician or clinical psychologist with 
established reliability by administering Module 3(n=16) or Module 4(n=25) of the Autism 
Diagnostic Observation Schedule(ADOS-G)(55). The revised algorithm was used for all 
modules(56, 57). Diagnoses for younger participants were also aided by administering the parent 
Autism Diagnostic Interview-Revised(ADI-R)(58)(n=17). In our final sample, 12 (27%) met 
DSM-IV-TR criteria for Autistic Disorder, 23 (52%) for Asperger’s Disorder, and 8 (18%) for 
PDD-NOS. Because substantial evidence suggests that most individuals with DSM-IV-based 
PDD diagnoses also meet DSM 5 criteria for a diagnosis of ASD(59), for ease of reference we 
herein used the DSM 5 designation. 
TD participants were recruited through flyers, online advertisements, and random 
sampling from a telemarketing list of local households eligible for participation, group-matched 
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to ASD participants on age, sex, and ethnicity. TD controls participated after a clinical interview 
including the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime 
Version for those under age 18(60) or the Structured Clinical Interview for DSM-IV Axis I 
Disorders for those ≥age 18(61). Additional exclusion criteria for all participants included 
contraindications to MRI, a history of premature birth(<36 weeks), low birth weight(<2000g), 
birth complications or injury, prior head trauma with loss of consciousness, seizures, or chronic 
medical illness. The Institutional Review Board of the New York State Psychiatric Institute 
approved the study procedures. An independent clinical monitor assessed the capacity for all 
adult ASD participants to provide informed consent. One participant was deemed to lack that 
capacity and therefore designated a surrogate to provide it. All children provided written assent. 
Intelligence quotient(IQ) for 1 ASD participant was assessed using the Wechsler 
Intelligence Scale for Children(62) and 1 using the Wechsler Adult Intelligence Scale(63); all 
other ASD and TD participants were assessed using the Wechsler Abbreviated Scale of 
Intelligence(64). As all ASD participants had fluent speech, full-scale IQ was available for all. 
The Edinburgh Inventory assessed laterality of handedness(65), and Hollingshead’s four-factor 
index estimated socioeconomic status(66). 
MRI Scanning & Processing 
All participants were unsedated for the scan. Details for scanning procedures, MRI pulse 
sequences, scan times, and image processing methods are provided in Supplementary Materials. 
Statistical Analyses  
All group-level statistical analyses employed a general linear model(GLM) at each voxel 
of the spatially normalized, individual rCBF maps, while covarying for age and sex, applying a 
False Discovery Rate (FDR) procedure at FDR=0.05 to control for false positives and color-
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coding voxels on the T1 template where P-values survived the FDR procedure. All statistical 
models were hierarchically well-formulated, with any interaction terms including the component 
main effects. Our a priori hypothesis assessed the main effect of diagnosis on rCBF in all 
participants with no other covariates or interactions in the model. We also assessed the 
influences of FSIQ and medication use on our findings in post hoc analyses by covarying 
separately for FSIQ and psychotropic medication use and by applying again our model for a 
priori hypothesis testing while excluding any ASD participants who were taking psychotropic 
medications at the time of scan. 
Secondary analyses assessed the moderating effects of age, sex, and FSIQ on group 
differences in separate models that included the respective interactions with their component 
main effects. These interactions assessed whether the slopes of the correlations differed across 
the ASD and TD control groups. In addition, within the ASD group we assessed the correlations 
of rCBF with Total and Domain scores on the developmentally appropriate ADOS module and 
with standardized Total and Subscale scores on SRS, while covarying for age and sex. We also 
assessed the voxel-wise correlations of rCBF with MRS-based measures of NAA metabolite 
levels as a continuous variable, and we compared rCBF values in the 6 ASD participants in 
whom we previously detected the presence of lactate with 30 ASD participants in whom we did 
not detect the presence of lactate. 
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RESULTS 
Sample Characteristics 
 The ASD and TD samples did not differ significantly in age, sex, ethnicity, FSIQ, 
handedness, or socioeconomic status(Table 1). By design, all SRS domain scores were higher in 
the ASD sample (all P<10-11), reflecting more severe social symptoms(Table 1). Fourteen of the 
44 ASD participants (and no TD participants) were taking psychotropic medication at the time of 
scan: stimulants(n=5), antidepressants(n=7; includes SSRIs and SNRIs), lithium(n=2), 
anticonvulsants/mood stabilizers(n=1), antipsychotics(n=4), benzodiazepine(n=2), MAOI(n=1), 
and non-stimulant ADHD medication(n=2) (these total >n=14 because some were taking 
multiple medications).  
[Table 1] 
Group Comparisons of rCBF 
ASD compared with TD participants had higher rCBF values throughout large expanses 
of white matter, primarily in frontal regions comprising the centrum semiovale(CS), corona 
radiata(CR), and internal capsule(IC) bilaterally. They also had greater rCBF bilaterally in gray 
matter of the caudate(Cd) and lenticular nucleus(L) more dorsally, the ventral striatum(VS), 
orbitofrontal cortex(OFC), and amygdala(Am). 
[Figure 1] 
Correlations of rCBF with ASD Symptom Measures 
Within the ASD group, rCBF correlated positively with the Total ADOS score in much 
of the same frontal white matter regions where a main effect of diagnosis was located(CS,CR), 
as well as within the hypothalamus, hippocampus, and middle temporal gyrus(Fig.1). The social 
affect domain score of the ADOS almost exclusively contributed to this correlation, with little or 
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no contribution from the repetitive behaviors domain score(Supplemental Figs.S22-S23). Of the 
various SRS subscale scores, social awareness correlated most robustly with rCBF measures, 
both within more dorsal white matter of the frontal lobe(CS), as well as in gray matter of the 
hypothalamus, hippocampus, middle temporal gyrus, basal ganglia(Cd,L,VS), amygdala, 
hippocampus, and brainstem(Supplemental Figs.S24-S28). 
Moderators of Diagnosis Effect 
Age significantly moderated the effects of diagnosis in the subgenual, pregenual, and 
dorsal ACC, inferior frontal gyrus, DLPFC, occipital gyrus, middle and inferior temporal gyrus, 
and amygdala(Fig.2), with the effects deriving in each instance from a steeper inverse correlation 
of rCBF with age in the ASD group than in TD controls(Fig.3). 
Sex significantly moderated the effect of diagnosis, though localized almost exclusively 
to the subgenual and pregenual ACC and small portions of the caudate, ventral striatum, and 
amygdala(Fig.2), with the effects deriving in each case from a reversal in the ASD group of the 
female>male rCBF differences present in TD controls(Fig.3). 
FSIQ also significantly moderated the effect of diagnosis within frontal white 
matter(CR,CS,IC), hypothalamus, and insular cortex(Fig.2), with the effect in each case deriving 
from a steeper decline in FSIQ with increasing rCBF, and more broadly throughout frontal white 
matter and subcortical gray matter, in the TD controls than in the ASD participants(Fig.3). 
[Figures 2&3] 
Correlations of rCBF with MRS Metabolites 
In the ASD and TD groups separately and combined, rCBF correlated inversely with 
NAA metabolite levels throughout frontal white matter, as well as in white matter of the internal 
and external capsules(Fig.4). The 6 ASD participants who had detectable lactate in their brains, 
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compared with the 30 who did not, had significantly lower rCBF in the white matter of the CC 
genu and posterior CS, and in gray matter of the DPFC and pregenual ACC. They also had 
higher rCBF values in the midcingulate cortex(Fig.4). 
[Figure 4] 
Post Hoc Analyses 
We conducted post hoc analyses to assess the effects of potential confounds on our 
findings. Covarying for FSIQ in our models had negligible effects on our findings(Supplemental 
Figs. S29-S31). Likewise, covarying for the use of psychotropic medications at the time of MRI 
scan had negligible effects, as did excluding from analyses those ASD participants taking 
psychotropic medications, though maps were overall somewhat less statistically significant 
because of reduced statistical power associated with fewer participants(Supplemental Figs.S32-
S37). Covarying for total cortical gray matter or total white matter volumes also had no 
discernible effects on our findings(Supplemental Figs.S38-S39). Finally, we also conducted our 
primary analyses (shown in Fig.1) separately in youth(≤ 21 years; N=20) and adults(>21 years; 
N=24); despite reduced statistical power, hyperperfusion was present in both groups, with the 
frontal locations most prominent in youth and dorsal parietal location more prominent in the 
adults(Supplemental Fig.S40). rCBF correlations with ADOS total scores were stronger in ASD 
adults, whereas SRS Awareness correlations were stronger in ASD youth(Supplemental 
Figs.S41-S42).  
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DISCUSSION 
 To the best of our knowledge, this is the first report of widespread hyperperfusion in 
ASD, and the first to report voxelwise correlations of rCBF with NAA metabolite concentrations 
throughout the brain.  
Hyperperfusion in ASD 
Hyperperfusion was present throughout frontal white matter (WM) and subcortical gray 
in ASD participants of all ages and in both sexes. rCBF correlated positively with measures of 
socialization deficits within the ASD group, including social affect domain scores on the ADOS 
and the social awareness subscale of the SRS, in regions where ASD hyperperfusion in group 
comparisons of rCBF were greatest. 
Our findings of WM hyperperfusion are consistent with one prior FDG PET brain 
metabolism study reporting higher metabolic rates in the WM of 25 ASD compared with 55 TD 
adults performing a verbal learning task, with the greatest increases in prefrontal WM and 
anterior limb of the internal capsule(23). They are also consistent with findings from numerous 
MRI(67, 68) and DTI(69, 70) studies reporting volumetric and organizational WM abnormalities 
in ASD, and with postmortem findings of fewer long axons, more short local axons, and thinner 
myelin(71, 72), which together suggest that compromised integrity of axons or oligodendrocytes 
may be the anatomical basis for reported long-range underconnectivity and local 
overconnectivity in functional MRI studies(34-45). 
CNS WM consumes approximately one-third the energy of gray matter(1-5) due to the 
greater energy efficiency of axon action potentials and especially WM synapses(73), with most 
WM energy devoted to maintaining resting potentials and various housekeeping tasks(73, 74). 
Hyperperfusion in ASD could derive from pathology in any one or a combination of these 
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maintenance processes in neuronal axons, the most abundant cellular tissue in WM and its 
largest component by volume. 
Oligodendrocytes, which comprise approximately 5% of all cells and 10-15% of all 
human glial cells in the brain(75, 76), ensheath WM axons with myelin to speed saltatory 
conduction(77). Their pathological functioning could alter myelination and, secondarily, WM 
metabolism and perfusion. Myelination is particularly important for finely calibrating conduction 
speeds and coordinating signals over long axons, which fMRI studies have suggested is a 
prominent disturbance in ASD(34-45). Most new myelin in adulthood is formed through an 
activity-dependent, plastic remodeling of the number, length, and thickness of preexisting myelin 
sheaths(37, 78-85). Approximately 20% of new myelin in adulthood also derives from the 
neuronal activity-dependent differentiation of oligodendrocyte precursor cells (OPCs) into new 
oligodendrocytes(85-87). Thus primary abnormalities in oligodendrocytes could produce altered 
WM metabolism and blood flow or, alternatively, abnormalities secondary to disturbances in 
axonal activity, whether from molecular or genetic defects in ASD or altered experiences 
associated with the illness, that in turn could trigger ongoing, activity-dependent myelin 
remodeling and its attendant increased metabolic demands. 
Astrocytes, the most abundant glial cell type in the CNS, constitute nearly half the 
volume of WM and contribute significantly to WM metabolism and blood flow(88). They play 
an essential supporting role in OPC proliferation and differentiation, production of myelin(89), 
and formation of the blood-brain barrier. They take up potassium and glutamate released into the 
interstitial fluid to sustain and modulate high-frequency neuronal firing. Though not electrically 
excitable, they form a large network of astrocyte signaling through gap junctions that propagates 
Ca+2 and ATP waves over long-distances(90, 91). These properties of astrocytes are increasingly 
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believed to play an important role in learning, memory, and intelligence(92), and genetic 
mutations affecting astrocyte functioning even produce ASD-like phenotypes of maturational 
delay, intellectual disability, and seizures(89). Altered astrocyte metabolism could account for 
our perfusion findings. 
Microglia, the least abundant glial cell type, are the primary responders in a CNS cellular 
immune response. Their relative scarcity makes their metabolism itself an unlikely cause of 
hyperperfusion in ASD, though the inflammatory responses that they generate could increase 
perfusion. Excessive microglial cell number and activation have been reported in previous PET 
and postmortem studies of ASD(93-95), and the reactive oxygen species and proinflammatory 
cytokines they generate could produce the impaired mitochondrial functioning suggested in prior 
studies(96), including one study of our participants(46). 
Hyperperfusion was also present in the basal ganglia and amygdala. Though 
predominantly gray matter structures, they do contain axons, myelin, and glia(97, 98), and 
therefore a disturbance affecting only one of these cell components could produce 
hyperperfusion in both white and gray matter.  
Interactions with Age 
We detected a significantly steeper inverse correlation of rCBF with age in the ASD 
group than in TD controls throughout much of cortical gray matter, but most significantly in the 
ACC, DLPFC, amygdala, and several other cortical gray matter regions, with rCBF generally 
higher in children and either similar or lower in adults with ASD compared with 
controls(Fig.2b). Thus the hyperperfusion detected in ASD across all ages in WM and 
subcortical gray was also present in cortical gray matter and amygdala, but primarily in ASD 
children. Prior 15O PET studies have reported declining cerebral metabolic rates(1-5) and blood 
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flow(1-3, 5) with age in cortical gray matter in healthy individuals; age correlates generally have 
not been reported in ASD. We detected an age-related decline of rCBF in healthy individuals 
only in occipital cortex. The decline in other cortical regions was in ASD participants, and in the 
direction toward values in healthy controls with advancing age, suggesting either that rCBF 
normalizes with age in cortical gray or that values close to normal in those regions may be a 
marker for ASD illness that persists into adulthood. By extension, higher rCBF values in children 
could also represent some kind of adaptive response to the presence of illness. Myriad cellular 
aging processes could account for the age-related decline in cortical rCBF in ASD, including: 
fewer neurons(99), dendritic arbors, or spines; reduced activity of the synaptic sodium/potassium 
pump and resting membrane potential(100); or less oxygen consumption and energy production 
from neuronal mitochondria in older compared with younger ASD participants(101). 
Interactions with Sex 
We detected a significant sex-by-diagnosis effect on rCBF in limbic regions, including 
subgenual ACC, ventral striatum, and amygdala, as well as parietal WM(Fig.2). In each instance, 
rCBF was greater in TD females than TD males, but this sex difference reversed in ASD, driven 
by particularly high values in ASD males, higher than in either TD males or females(Fig.2b). 
These findings suggest that, for reasons unknown, the perfusion abnormalities and cellular 
processes underlying them in ASD are disproportionately greater in males in limbic gray matter 
regions, perhaps contributing to the well-known male predominance in prevalence of ASD and to 
the more severe problems with externalizing and prosocial behaviors commonly found in ASD 
males(102, 103). 
Interactions with IQ  
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We detected a significant IQ-by-diagnosis interaction effect on rCBF values in frontal 
WM and subcortical gray matter that derived from a significant decline in rCBF with increasing 
IQ in the TD group, a correlation that was absent in ASD participants(Fig.2a&b). The 
hyperperfusion present in most members of the ASD group, though attenuated in younger ASD 
participants, destroyed the normal association of IQ with rCBF in these regions(Fig.3). The 
inverse correlation of resting rCBF with IQ in the TD controls is consistent with the neural 
efficiency hypothesis of intelligence, which posits that those with higher intelligence process 
information more efficiently, using less energy to accomplish any given task(104). Presumably 
this greater efficiency is present even in the “resting” brain that is not explicitly engaged in 
performing any task. The cellular and molecular determinants of greater efficiency are unknown, 
but could include improved synaptic or network connectivity(105), myelination(105), or 
maintenance of resting potentials and other housekeeping functions(106, 107). These need not be 
the same determinants as those that increase perfusion in ASD, but if they are the same, then 
disturbances in myelin remodeling or axon housekeeping functions are potential culprits in ASD, 
as both would require increased metabolism to support intellectual functioning at its highest 
potential. 
Metabolite Correlations 
rCBF throughout frontal WM in the ASD group correlated inversely with NAA 
metabolite levels. We reported elsewhere significantly lower NAA concentrations in the ASD 
group compared with controls(47). Thus, greater rCBF accompanied lower, and increasingly 
abnormal, NAA levels. As findings from prior studies indicate that reduced NAA concentrations 
represent a reduced density or functioning of axonal mitochondria(49, 50), then reduced frontal 
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WM mitochondria could suggest that increased frontal WM rCBF and metabolism represents a 
compensatory process in ensheathing glia to maintain the energy state of WM axons. 
The possibility of compensation is bolstered by evidence that glia support the formidable 
metabolic housekeeping demands of myelinated axons, which are challenged by sparse 
mitochondria and slow passive diffusion of nutrients across nodes of Ranvier(108). Myelinating 
oligodendrocytes couple with associated axons to support neuronal metabolism under 
stress(109), in part through release of exosomes containing trophic substances(73, 74, 109, 110), 
and in part through shuttling of lactate and pyruvate to axons to serve as substrates for aerobic 
ATP production(111). Axonal firing stimulates further oligodendrocyte production of lactate and 
pyruvate through release of glutamate, which activates oligodendrocyte NMDA receptors to 
stimulate uptake of glucose and glycolysis, thereby maintaining energy supplies to axons(89, 
112, 113). Finally, the myelin sheath has been proposed as an ectopic site of glucose combustion 
and ATP generation for use by myelinated axons(74, 114-116), though direct experimental and 
mathematical modeling support for ATP generation in myelin sheaths is lacking(117). 
The positive correlations of rCBF with measures of social impairment we observed 
suggest that this putative compensatory response is either unsuccessful or incomplete, because 
fully successful compensation would produce an inverse correlation. In the presence of 
unsuccessful or incomplete compensation, however, greater reductions of NAA and axonal 
metabolism would produce more severe symptoms and a proportionately greater compensatory 
response in glial cell metabolism – i.e., it would produce the observed positive associations of 
social impairment with rCBF. Alternatively, sustained increases in myelin synthesis by 
oligodendrocytes in ASD WM could deplete the associated axons of NAA, because more myelin 
synthesis would require transportation of more NAA from neurons to oligodendrocytes for 
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cleavage and use of its acetate moiety(118, 119). Increased myelin synthesis therefore could 
account for both reduced NAA in axons but increased rCBF in metabolic support of myelin 
synthesis. Human postmortem and imaging studies, however, generally have not provided 
evidence for excessive, ongoing myelination in ASD. 
Limitations Though our sample comprised ASD participants with a wide range of intellectual 
and social functioning, mean IQs were by design comparable to TD participants to limit the 
potential confounding effects of IQ differences on our findings. This sample selection, however, 
limits the generalizability of our findings to persons who are more severely affected with ASD, 
at least with respect to language and cognitive functioning. In addition, a larger sample size 
would improve statistical power and the stability of interaction effects. Longitudinal imaging 
studies are needed to support developmentally based interpretations of our findings(10). 
Conclusion 
Extensive resting frontal WM hyperperfusion in ASD suggests increased metabolic 
demands of either axons or glia or both. Positive correlations of rCBF with measures of social 
impairment in the same WM regions suggest that either increased perfusion partially generates 
those symptoms or is a proportionate response to their presence. The altered associations of 
rCBF with IQ moreover suggests impaired neural efficiency in frontal WM. The combination of 
reduced NAA levels with proportionally greater rCBF values in frontal WM suggests that glial 
cells are attempting unsuccessfully or incompletely to compensate for reduced axonal 
metabolism in ASD. The most parsimonious explanation for all these findings is the presence of 
axonal pathology, including reduced NAA and altered mitochondrial metabolism, that disrupts 
one or more components of the housekeeping processes supporting axonal functioning, thereby 
reducing the efficiency of information processing. These disruptions trigger compensatory 
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responses from supporting glial cells to support axon metabolism and proportionately increase 
rCBF to affected WM. The compensatory response is only partial, however, and in the ASD 
group disrupts the normal association of greater efficiency of neural processing with increasing 
IQ observed in the TD group. These findings, if confirmed, suggest cellular and molecular 
targets for studies of axonal pathology and development of novel therapeutics to bolster glial 
compensatory responses in ASD. 
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FIGURE LEGENDS 
Figure 1. Group Comparisons and Symptom Correlations The right sides of the images 
correspond to the right side of the brain. All analyses control for the effects of age and sex, and 
the significance levels in all maps are FDR-corrected for the number of statistical comparisons. 
First Row Shown is the T1-weighted anatomical template to which rCBF values for all 
participants were mapped at transaxial slice levels positioned parallel to the Anterior 
Commissure-Posterior Commissure (AC-PC) line, and corresponding to the positioning of the 
statistical maps shown in the other rows. The z-values represent slice level (in millimeters) in the 
Talairach coordinate system. 
Second Row This shows the statistically significant differences in rCBF values between the ASD 
group and TD controls while covarying for age and sex, displayed at a threshold of P<0.05 after 
correction for multiple comparisons. Voxels in red indicate significantly increased rCBF, and 
blue voxels reduced rCBF, in ASD relative to controls. Perfusion values at rest in the ASD group 
were higher bilaterally throughout white matter of all the frontal lobe, internal capsule, and 
dorsal parietal lobe, and in gray matter of the basal ganglia, thalamus, and amygdala. 
Third & Fourth Rows Red and blue voxels represent, respectively, significant positive or inverse 
correlations of ADOS total scores and SRS social affect scores with rCBF values in the ASD 
group, after FDR correction for multiple comparisons.  
Abbreviations Am: amygdala; BS: brainstem; CC: corpus callosum; Cd: caudate; CR: corona 
radiata; CS: centrum semovale; H: hippocampus; IC: internal capsule; IF: inferior frontal gyrus; 
IT: inferior temporal gyrus; L: lenticular nucleus; MB: midbrain; MT: middle temporal gyrus; 
OFC: orbitofrontal cortex; OR optic radiations; PCC: posterior cingulate cortex; ST: superior 
temporal gyrus; Th: thalamus; VS: ventral striatum 
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Figure 2 Modifying Effects of Age, Sex, and FSIQ the significance levels in all maps are FDR-
corrected for the number of statistical comparisons 
Left Panel In the first two columns are maps showing the significance of age correlations with 
resting rCBF at each voxel in the ASD and TD groups separately, while covarying for sex. Red 
and blue voxels represent, respectively, significant positive or inverse correlations of age with 
rCBF values. The third column shows effects of the interaction of age with diagnosis on rCBF at 
each voxel, or the voxels where the correlations of age with rCBF differ significantly across the 
ASD and TD groups, while covarying for sex and including the main effects of age and 
diagnosis in a hierarchically well formulated statistical model. 
Middle Panel In the first two columns are maps showing the significance of sex difference in 
rCBF at each voxel in the ASD and TD groups separately, while covarying for age. Red and blue 
voxels represent significantly higher rCBF values in males or females, respectively. The third 
column shows effects of the interaction of sex with diagnosis on rCBF at each voxel, or the 
voxels where sex differences in rCBF differ significantly across the ASD and TD groups, while 
covarying for age and including the main effects of sex and diagnosis in a hierarchically well 
formulated statistical model. 
Right Panel In the first two columns are maps showing the significance of correlations of FSIQ 
(full scale IQ) with resting rCBF at each voxel in the ASD and TD groups separately, while 
covarying for age and sex. Red and blue voxels represent, respectively, significant positive or 
inverse correlations of FSIQ with rCBF values. The third column shows effects of the interaction 
of FSIQ with diagnosis on rCBF at each voxel, or the voxels where the correlations of FSIQ with 
rCBF differ significantly across the ASD and TD groups, while covarying for age and sex and 
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including the main effects of FSIQ and diagnosis in a hierarchically well formulated statistical 
model. 
Abbreviations Am: amygdala; Cd: caudate; CR: corona radiata; CS: centrum semovale; dACC: 
dorsal anterior cingulate cortex; DLPFC: dorsolateral prefrontal cortex; Hy: hypothalamus; IC: 
internal capsule; IF: inferior frontal gyrus; Ins: insula; IT: inferior temporal gyrus; LG: lingual 
gyrus; MO: middle occipital gyrus; OFC: orbitofrontal cortex; OR optic radiations; pgACC: 
pregenual anterior cingulate cortex; PCC: posterior cingulate cortex; sgACC: subgenual anterior 
cingulate cortex; ST: superior temporal gyrus; VS: ventral striatum 
Figure 3. Data Displays for Age, Sex, and FSIQ Effects These are shown for representative 
regions indicated from a slice taken from Figure 2, shown above each plot in the statistical map. 
The line leading from the regional label to the image indicates the voxels with the images that 
were sampled to generate the data shown in the scatterplots. The scatterplots illustrate the age-
related decline in rCBF in most cortical regions for ASD and the inverse correlation of rCBF 
with full scale IQ (FSIQ) in the TD but not ASD group. Bar graphs for sex effects demonstrate in 
ASD participants the reversal of female>male sex differences present in the TD group. Error bars 
represent standard error. 
Figure 4. Correlations of rCBF with NAA Metabolite Levels and Lactate Top 3 Rows show 
the voxel-wise correlations of NAA level with rCBF in the ASD (N=36, 29 males, 7 females, 
mean age 25.6 years) and TD (N=63, 48 males, 15 females, mean age 22.3 years) groups 
combined (top row) and separately, while covarying for age and sex. Significance levels are 
FDR-corrected for the number of statistical comparisons. Primarily inverse correlations (blue 
voxels) are present in the ASD group in frontal white matter of the centrum semiovale (CS) and 
corona radiata (CR), internal capsule (IC), and external capsule (EC), and in the midcingulate 
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cortex (MCC) and posterior cingulate cortex (PCC). In the TD group, inverse correlations are 
seen in similar locations, but are smaller in spatial extent and weaker in statistical significance; 
positive correlations (red voxels) in the TD group are scattered throughout cortical gray matter 
(insula: Ins; posterior cingulate cortex: PCC) and inverse correlations are present in frontal white 
matter (CS, CR). Bottom Row The 6 ASD participants with detectable lactate compared with the 
30 without detectable lactate had significantly lower rCBF values (blue voxels) in the dorsal 
prefrontal cortex (DPFC), pregenual anterior cingulate cortex (pgACC), posterior cingulate 
cortex (PCC), genu of the corpus callosum (gCC), and posterior white matter of the centrum 
semiovale (CS) and parieto-occipital (PO) region. 
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Table 1. Participant Characteristics    
 ASD TD 
Test 
Stat 
df P-value 
N 44 66    
Mean Age 24.9±15.6 22.0±11.2 T=1.1 108 0.26 
Age Range 5.9–60.7 6.9–59.0    
Sex 32m/12f 50m/16f ×2=0.13 1 0.72 
SES 48.8±10.5 53.5±11.1 T=1.90 85 0.06 
Handedness 38R,6L 62R,4L ×2=2.8 1 0.11 
Ethnic/Racial Minority 9 18 ×2=0.77 1 0.38 
Framewise Motion (mm) 0.17±0.06 0.16±0.06 T=0.88 109 0.37 
RMS Motion (mm) 0.09±0.03 0.09±0.04 T=0.89 109 0.37 
FSIQ 112.3±18.3 116.7±10.6 T=1.42 60.8 0.16 
ADOS Totala 10.8±4.1 –     
ADOS Social Affect 9.1±3.8 –    
ADOS Restrict & Repet Beh 1.7±1.6 –    
SRS Totalb 83.0±27.2 20.8±18.3 T=12.1 61.8 4x10-14 
SRS Awareness 10.6±3.3 5.1±3.2 T=7.8 85 1x10-11 
SRS Cognition 15.4±4.8 3.1±3.6 T=13.3 66.7 2x10-20 
SRS Communication 28.4±9.0 6.2±7.2 T=12.8 85 1x10-21 
SRS Motivation 13.7±5.3 3.5±3.3 T=10.4 58.8 7x10-15 
SRS Mannerisms 15.6±6.9 3.0±3.8 T=10.1 53.9 4x10-14 
aADOS scores were available for 41 ASD participants 
bSRS scores were available for 38 ASD and 49 TD participants 
ADOS=Autism Diagnostic Observation Schedule; Restrict & Repet Beh=Restricted and Repetitive Behaviors 
SRS=Social Responsiveness Scale; Awareness=Social Awareness; Cognition=Social Cognition; Communication=Social 
Communication; Motivation=Social Motivation; Mannerisms=Restricted Interests and Repetitive Behaviors 
SES=socioeconomic status measured with the Hollingshead; this was available in 31 ASD and 56 TD participants 
FSIQ was available in 43 ASD and 65 TD participants 
RMS=Root Mean Square motion estimate during the ASL scan 
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Section 1: MRI Scanning Procedures and Pulse Sequences  
Images were acquired on a GE Signa 3T (Tesla) HDx system with an 8-channel, receive-only head coil. 
ASL We optimized our Pulsed Arterial Spin Labeling (PASL) perfusion sequence for parallel imaging at 3T using a PICORE (Proximal 
Inversion with Control for Off-Resonance Effects) QUIPSS II (Quantitative Imaging of Perfusion using a Single Subtraction) pulse 
sequence (1). We placed a 9-cm tagging slab 16-mm below the proximal edge of the imaging volume. We acquired the control 
images by applying off-resonance adiabatic hyperbolic secant RF pulse with the same frequency offset as that for the labeled images 
without the slice-selective gradient, so as to control for off-resonance effects of the inversion pulses used for acquiring the labeled 
images. We used a single-shot, gradient-echo, echo planar imaging (EPI) sequence for image acquisition, with time to QUIPSS 
saturation 𝑇𝐼1=600 ms and inversion time of the first slice 𝑇𝐼2 =1300 ms. Acquisition parameters included FOV 24 cm, 64x64 matrix, 
TE(echo time)/TR (repetition time)=24/2300ms, flip angle 90°, slice thickness 6 mm, inter-slice spacing 0.5 mm, providing a nominal 
spatial resolution of 3.75x3.75x6.5 mm. We acquired 18 slices from inferior to superior in sequential order. Each ASL scan with 151 
acquisitions plus 5 dummy images required 5 min 59 sec.  
A separate M0 scan using gradient-echo EPI with TR of 15sec was acquired at the same resolution and slice position as the ASL data. 
The M0wm from white matter is measured and then used in the off-line computation of rCBF (1).  
ASL Localizer We also acquired a T1-weighted, localizer image with high in-plane resolution in the same slice locations as the ASL 
data for coregistering each participant’s ASL data to its T1-weighted anatomical MR image. The localizer image was acquired using a 
2D, fast spin echo pulse sequence with echo train length=9, TR = 2150ms, TE = 9.94ms, TI = 840ms, flip angle = 90o, in-plane 
resolution = 0.94 x 0.94 mm2, slice thickness = 6.5mm. Total acquisition time = 1 min, 46 sec. 
MRS data were acquired in 6 axial-oblique slabs (2-mm gap) parallel to the anterior commissure-posterior commissure (AC-PC): one 
slab below, one slab containing, and 4 slabs above the AC-PC. We used a water-suppressed MPCSI sequence with TR/TE=2800/144 
ms, voxels 10x10x10 mm3, and suppressed lipid signal from the scalp using eight saturation bands. Scan time, including shimming, 
was 20 min. 
MRS Localizer A “localizer” MRI with voxels 0.98x0.98x10 mm3 was acquired in register with MPCSI and was used to coregister and 
normalize MPCSI data into the common coordinate space of a template brain. Whole-brain T1-weighted (T1) MRI was obtained 
using 3D spoiled gradient recall with 0.98x0.98x1.0 mm3 voxels. The T1 was used to prescribe MPCSI and to segment the brain into 
gray and white matter. 
Additional Sequences included Anatomical MRI, Diffusion Tensor Imaging, Task-Based functional MRI, and Resting-State functional 
MRI 
Total Scan Time was approximately 75 minutes, with additional time included for participant breaks to rest and move about, and 
reacquire sequences that had evidence of motion artifact.  
Section 2: Image Processing Methods 
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ASL We aligned the PASL brain images and the M0_WM image to the first PASL image for each participant in native imaging space to 
correct for head motion. We spatially smoothed the coregistered PASL images using a Gaussian kernel of 6mm FWHM (Full Width at 
Half Maximum) to improve signal-to-noise ratio while avoiding loss of spatial precision in locating our effects of interest. We 
generated a brain mask for each participant based on the mean PASL image. We constructed for each participant a voxel-wise map 
of rCBF from the PASL time series and M0_WM image using in-house software: (1) We pair-wise subtracted the control images from 
the labeled images; (2) From the average of the subtracted images, we calculated rCBF at each voxel as  𝑟𝐶𝐵𝐹 =
 
6000∗∆𝐼
2𝛼∗𝑀0_𝐵∗𝑇𝐼1∗𝑒𝑥𝑝(−𝑇𝐼2/𝑇1_𝐵)
 , where ∆𝐼 is the image difference obtained in step 1; α is the tagging efficiency, for which we used the 
default value of 0.9; 𝑇𝐼1 = 600 ms is the time to QUIPSS saturation; 𝑇𝐼2 = 1300 ms is the inversion time of the first slice and is slice 
time corrected for the rest of the slices in the imaging volume; and T1B is the T1 of blood, for which we used the default value of 1664 
ms (2); M0_B is the MR signal from a voxel filled with arterial blood, estimated from the M0_WM map as
TETT
WMB
BWMerMM
)/1/1(
_0_0
22 −=
  
where r is the proton density ratio of blood, for which we used a default value of 1.06; and where the default values for T2WM and T2B 
were 70 ms and 200 ms, respectively (1, 3, 4). We used a 6 degrees-of-freedom rigid-body transformation such that mutual 
information (5) is increased to coregister the anatomical images to the localizer images for each participant. Subsequently, each 
participant’s anatomical image is used as an intermediary source to coregister the rCBF images to a template brain by applying a 
similarity (5) followed with a nonlinear transformation based on fluid flow (6). We selected a single individual brain as the template 
brain, which was morphologically the most representative of the brains for TD participants (7). 
We quantified the amount of head motion in the ASL data of each participant using two summary statistics, Root Mean 
Squared (RMS) (8)  and Mean Frame-wise Displacement (FD) metric sums differentiated realignment estimates (9), derived from 
three translational (x,y,z) and three angular rotational (roll, pitch, yaw). Motion during the ASL scan was minimal and comparable 
across groups (Table 1). 
MRS Following time-domain preprocessing, MPCSI data were transformed into the frequency domain and loaded into a 3DiCSI 
software package (http://hatch.cpmc.columbia.edu/software.html) that identified brain-internal MPCSI voxels. Spectra were fit for 
NAA (N-acetylaspartate), Glx, Cr (creatine), Cho (choline) and lipids using Gaussian-Lorentzian curves and least-squares estimation. 
Areas under the curves estimated metabolite concentrations in each voxel. Data were quality controlled by inspection of each 
spectrum, rejecting spectra with lipid contamination, insufficient water suppression, unresolved Cr and Cho, or linewidth > 12 Hz. 
We calculated background noise as the standard deviation of the part of the real spectrum free from metabolite signal, then 
generated a spectroscopic image for NAA as the ratio of peak area to background noise for each voxel, accounting for variations in 
receiver and transmitter gain. The brain was extracted from each T1 volume, warped into a cross-participant template, and 
segmented into gray and white matter. We corrected the spectroscopic images for partial-voluming (variable gray- vs. white-matter 
content across MPCSI voxels) and for the MPCSI point-spread function (dispersion of the MR signal into neighboring voxels) using 
linear regression to estimate the concentration of that metabolite in gray matter and white matter in each voxel and neighboring 
voxels. We resampled metabolite levels from the low-resolution MPCSI to the high-resolution T1 during spatial normalization, which 
Peterson et al. Supplement
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required coregistering and nonlinearly warping the MPCSI volume for each participant onto the T1 template brain. We then used the 
T1 image and high-resolution localizer to coregister each metabolite image to the study template to permit correlation of NAA levels 
with rCBF measures at each voxel. Processing for the detection of lactate in this sample has been described in detail previously (10). 
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Supplementary Figure S1. T1-Weighted Anatomical Template 
Shown are all slices of the T1-weighted anatomical template on which statistical maps were overlaid, with transaxial slice levels 
positioned parallel to the Anterior Commissure-Posterior Commissure (AC-PC) line. The z-values represent slice level (in millimeters) 
in the Talairach coordinate system. The right sides of the images correspond to the right side of the brain. 
 
  
T1-Weighted Anatomical Template
Figure 1
Peterson et al. Supplement
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
 
Supplementary Figure S2. Main Effect of Diagnosis for All Slices 
This shows the statistically significant differences in rCBF values between the ASD group and TD controls for all slices while covarying 
for age and sex, displayed at a threshold of P<0.05 after correction for multiple comparisons. Voxels in red indicate significantly 
increased rCBF, and blue voxels reduced rCBF, in ASD relative to controls. Highlighted slices (with their z-level Talairach coordinates) 
are those displayed in Figure 1 of the main text. 
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Supplementary Figure S3. Correlation of rCBF with ADOS Total Scores for All Slices 
Shown here are all slices for the statistically significant correlations of ADOS Total scores with rCBF values in the ASD group, while 
covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of ADOS Total scores with rCBF values in the ASD group. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S4. Correlation of rCBF with SRS Social Awareness Scores for All Slices 
Shown here are all slices for the statistically significant correlations of SRS Awareness scores with rCBF values in the ASD group, 
while covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue 
voxels represent, respectively, significant positive or inverse correlations of SRS Awareness scores with rCBF values in the ASD group. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S5. Scatterplots for the Correlations of rCBF with ADOS Total and SRS Awareness Scores 
These are shown for representative regions indicated above each plot in the statistical map in slices selected from the statistical 
maps representing the correlation of rCBF with ADOS Total or SRS Awareness scores. The line leading from the regional label to the 
image indicates the voxels with the images that were sampled to generate the data shown in the scatterplots. The effects of age and 
sex are partialed out of the rCBF values (hence the negative values for adjusted rCBF values on the y-axis. The scatterplots show that 
the data are well distributed around the regression lines. 
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Supplemental Materials Section 3b: 
Age Effects Showing All Slices 
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Supplementary Figure S6. Correlates of rCBF with Age in the TD Group Only for All Slices 
This map shows the significance of age correlations with resting rCBF at each voxel in the TD group, while covarying for sex, in all 
slices. Red and blue voxels represent, respectively, significant positive or inverse correlations of age with rCBF values. Highlighted 
slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplementary Figure S7. Correlates of rCBF with Age in the ASD Group Only for All Slices 
This map shows the significance of age correlations with resting rCBF at each voxel in the ASD group, while covarying for sex, in all 
slices. Red and blue voxels represent, respectively, significant positive or inverse correlations of age with rCBF values. Highlighted 
slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplementary Figure S8. The Interaction of Diagnosis with Age in All Slices 
This map shows the significant effects of the interaction of age with diagnosis (ASD or TD) on rCBF at each voxel in all slices, while 
covarying for sex and including the main effects of age and diagnosis in a hierarchically well formulated statistical model. The 
interaction effect indicates voxels where the correlation of age with rCBF differs significantly across the ASD and TD groups. Red and 
blue voxels represent the mathematical sign (positive or negative, respectively) of the F-test statistic for the interaction. Highlighted 
slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplemental Materials Section 3c: 
Sex Effects Showing All Slices 
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Supplementary Figure S9. Sex Differences in rCBF within the TD Group Only for All Slices 
This shows all maps illustrating the significance of sex correlations with resting rCBF at each voxel in the TD group in all slices, while 
covarying for age. Red and blue voxels represent significantly larger rCBF values in males or females, respectively. Shown here are all 
slices for which data was collected in the brain. Highlighted slices (with their z-level Talairach coordinates) are those displayed in 
Figure 2 of the main text.  
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Supplementary Figure S10. Sex Differences in rCBF within the ASD Group Only for All Slices  
This shows all maps illustrating the significance of sex correlations with resting rCBF at each voxel in the ASD group in all slices, while 
covarying for age. Red and blue voxels represent significantly larger rCBF values in males or females, respectively. Shown here are all 
slices for which data was collected in the brain. Highlighted slices (with their z-level Talairach coordinates) are those displayed in 
Figure 2 of the main text. 
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Supplementary Figure S11. The Interaction of Diagnosis with Sex in All Slices 
This map shows the significant interaction effects of sex (male or female) with diagnosis (ASD or TD) on rCBF at each voxel in all 
slices, while covarying for age and including the main effects of sex and diagnosis in a hierarchically well formulated statistical 
model. The interaction effect indicates voxels where the correlation of age with rCBF differs significantly across the ASD and TD 
groups. Red and blue voxels represent the mathematical sign (positive or negative, respectively) of the F-test statistic for the 
interaction. Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplementary Figure S12. Correlates of rCBF with FSIQ in the TD Group Only for All Slices  
This shows all maps illustrating the significance of FSIQ correlations with resting rCBF at each voxel in the TD group in all slices, while 
covarying for age and sex. Red and blue voxels represent, respectively, significant positive or inverse correlations of FSIQ with rCBF 
values. Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplementary Figure S13. Correlates of rCBF with FSIQ in the ASD Group Only for All Slices  
This shows all maps illustrating the significance of FSIQ correlations with resting rCBF at each voxel in the ASD group in all slices, 
while covarying for age and sex. Red and blue voxels represent, respectively, significant positive or inverse correlations of FSIQ with 
rCBF values. Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplementary Figure S14. The Interaction of Diagnosis with FSIQ in All Slices 
This map shows the significant interaction effects of FSIQ with diagnosis (ASD or TD) on rCBF at each voxel in all slices, while 
covarying for age and sex and including the main effects of FSIQ and diagnosis in a hierarchically well formulated statistical model. 
The interaction effect indicates voxels where the correlation of FSIQ with rCBF differs significantly across the ASD and TD groups. 
Red and blue voxels represent the mathematical sign (positive or negative, respectively) of the F-test statistic for the interaction. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 2 of the main text. 
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Supplementary Figure S15. Voxelwise Correlation of rCBF with NAA Concentrations in the TD Group Only in All Slices 
Shown here are the voxel-wise correlations of NAA concentration with rCBF in the TD group (N=63, 48 males, 15 females, mean age 
22.3 years) in all slices, while covarying for age and sex. Significance levels are FDR-corrected for the number of statistical 
comparisons. Red and blue voxels represent, respectively, significant positive or inverse correlations of NAA levels with rCBF values. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 3 of the main text. 
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Supplementary Figure S16. Voxelwise Correlation of rCBF with NAA Concentrations in the ASD Group Only in All Slices  
Shown here are the voxel-wise correlations of NAA concentration with rCBF in the ASD group (N=36, 29 males, 7 females, mean age 
25.6 years) group in all slices, while covarying for age and sex. Significance levels are FDR-corrected for the number of statistical 
comparisons. Red and blue voxels represent, respectively, significant positive or inverse correlations of NAA levels with rCBF values. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 3 of the main text. 
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Supplementary Figure S17. Voxelwise Correlation of rCBF with NAA Concentrations in All Participants for All Slices  
Shown here are the voxel-wise correlations of NAA concentration with rCBF in the ASD (N=36, 29 males, 7 females, mean age 25.6 
years) and TD (N=63, 48 males, 15 females, mean age 22.3 years) groups combined in all slices, while covarying for age and sex. 
Significance levels are FDR-corrected for the number of statistical comparisons. Red and blue voxels represent, respectively, 
significant positive or inverse correlations of NAA level with rCBF values in the ASD group compared to the TD group. Highlighted 
slices (with their z-level Talairach coordinates) are those displayed in Figure 3 of the main text. 
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Supplementary Figure S18. rCBF in ASD Participants with or without Detectable Lactate for All Slices 
This map shows all slices for the voxel-wise statistical comparison of rCBF in ASD participants who had detectable lactate (N=6, __ 
males, __ females, mean age __ years) compared with the ASD participants who did not have detectable lactate at any voxel, while 
covarying for age and sex. Significance levels are FDR-corrected for the number of statistical comparisons. Red and blue voxels 
represent, respectively, significantly higher or lower rCBF values, respectively, in ASD participants who had detectable lactate. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 3 of the main text. 
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Supplementary Figure S19. Group Average Maps Contributing to Significant Group Differences in rCBF in Representative Slices 
Top Row: This is a map showing the group average rCBF at each voxel in the ASD group only, partialing out the effects of age and 
sex, for the slices shown in Figure 1 of the main text. 
Middle Row: This is a map showing the group average rCBF at each voxel in the TD group only, partialing out the effects of age and 
sex, for the slices shown in Figure 1 of the main text. 
Bottom Row: These are the statistically significant group differences (ASD vs TD) in rCBF while covarying for age and sex, displayed at 
a threshold of P<0.05 after correction for multiple comparisons, for the slices shown in Figure 1 of the main text. 
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Supplementary Figure S20. Average Perfusion in the TD Group in All Slices 
This is a map showing the group average rCBF at each voxel in all slices in the TD group only, partialing out the effects of age and sex. 
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Supplementary Figure S21. Average Perfusion in the ASD Group in All Slices  
This is a map showing the group average rCBF at each voxel in all slices in the ASD group only, partialing out the effects of age and 
sex. 
 
  
Z=+35
Z=+18 Z=+12 Z=+4
Z=-12
Z=+24
Z=-1
rC
B
F
(m
L
/1
0
0
g
/m
in
)
>
1
2
0
6
0
3
0
1
9
0
Perfusion: 44 ASD : Group Average Perfusion Maps
Average Perfusion in the ASD Group in All Slices
Figure 21
Peterson et al. Supplement
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
36 
 
 
 
 
 
Supplemental Materials Section 5a: 
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Supplementary Figure S22. Correlation of rCBF with ADOS Social Affect Scores for All Slices  
This shows the statistically significant correlations of ADOS Social Affect scores with rCBF values in the ASD group for all slices while 
covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of ADOS Social Affect scores with rCBF values in the ASD group.  
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Supplementary Figure S23. Correlation of rCBF with ADOS Restrictive and Repetitive Behaviors Scores for All Slices 
This shows the statistically significant correlations of ADOS Restrictive and Repetitive Behaviors scores with rCBF values in the ASD 
group for all slices while covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. 
Red and blue voxels represent, respectively, significant positive or inverse correlations of ADOS Restrictive and Repetitive Behaviors 
scores with rCBF values in the ASD group.  
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Supplementary Figure S24. Correlation of rCBF with SRS Total Scores for All Slices  
This shows the statistically significant correlations of SRS Total scores with rCBF values in the ASD group for all slices while covarying 
for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels represent, 
respectively, significant positive or inverse correlations of SRS Total scores with rCBF values in the ASD group.  
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Supplementary Figure S25. Correlation of rCBF with SRS Motivation Scores for All Slices  
This shows the statistically significant correlations of SRS Motivation scores with rCBF values in the ASD group for all slices while 
covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of SRS Motivation scores with rCBF values in the ASD group.  
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Supplementary Figure S26. Correlation of rCBF with SRS Mannerism Scores for All Slices  
This shows the statistically significant correlations of SRS Mannerism scores with rCBF values in the ASD group for all slices while 
covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of SRS Mannerism scores with rCBF values in the ASD group.  
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Supplementary Figure S27. Correlation of rCBF with SRS Communication Scores for All Slices  
This shows the statistically significant correlations of SRS Communication scores with rCBF values in the ASD group for all slices while 
covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of SRS Communication scores with rCBF values in the ASD group.  
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Supplementary Figure S28. Correlation of rCBF with SRS Cognition Scores for All Slices  
This shows the statistically significant correlations of SRS Cognition scores with rCBF values in the ASD group for all slices while 
covarying for age and sex, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of SRS Cognition scores with rCBF values in the ASD group.  
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Supplementary Figure S29. Effects of Diagnosis on rCBF while Covarying for FSIQ 
This shows the statistically significant differences in rCBF values between the ASD group and TD controls for all slices while covarying 
for age, sex, and FSIQ, displayed at a threshold of P<0.05 after correction for multiple comparisons. Voxels in red indicate 
significantly increased rCBF, and blue voxels reduced rCBF, in ASD relative to controls. Highlighted slices (with their z-level Talairach 
coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S30. Correlation of rCBF with ADOS Total Scores while Covarying for FSIQ 
Shown here are all slices for the statistically significant correlations of ADOS Total scores with rCBF values in the ASD group, while 
covarying for age, sex, and FSIQ, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue 
voxels represent, respectively, significant positive or inverse correlations of ADOS Total scores with rCBF values in the ASD group. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S31. Correlation of rCBF with SRS Awareness Scores while Covarying for FSIQ 
Shown here are all slices for the statistically significant correlations of SRS Awareness scores with rCBF values in the ASD group, 
while covarying for age, sex, and FSIQ displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue 
voxels represent, respectively, significant positive or inverse correlations of SRS Awareness scores with rCBF values in the ASD group. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S32. Effects of Diagnosis on rCBF while Excluding ASD Participants Taking Any Psychotropic Medication 
This map shows in all slices the statistically significant differences in rCBF values between a subset of the ASD group (N=29, 22 males, 
7 females, mean age 23.7 years) who were not taking any psychotropic medications at the time of the MRI scan and all TD controls 
(N=65, 49 males, 16 females, mean age 21.6 years) while covarying for age and sex, displayed at a threshold of P<0.05 after 
correction for multiple comparisons. Voxels in red indicate significantly increased rCBF, and blue voxels reduced rCBF, in ASD relative 
to controls. Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S33. Effects of Diagnosis on rCBF while Covarying for the Use of Any Psychotropic Medication at the Time 
of MRI Scan 
This map shows in all slices the statistically significant differences in rCBF values between the ASD group (N=43, 31 males, 12 
females, mean age 25.3 years) and TD controls (N=65, 49 males, 16 females, mean age 21.6 years) while covarying for age, sex, and 
the use of any psychotropic medication at the time of MRI scan, displayed at a threshold of P<0.05 after correction for multiple 
comparisons. Voxels in red indicate significantly increased rCBF, and blue voxels reduced rCBF, in ASD relative to controls. 
Highlighted slices (with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S34. Correlation of rCBF with ADOS Total Scores while Excluding ASD Participants Taking Any Psychotropic Medication  
This map shows in all slices the statistically significant correlations of ADOS Total scores with rCBF values, while covarying for age and sex, in a 
subset of the ASD group (N=28, 21 males, 7 females, mean age 23.0 years) who were not taking any psychotropic medications at the time of the 
MRI scan, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels represent, respectively, 
significant positive or inverse correlations of ADOS Total scores with rCBF values in the ASD group. Highlighted slices (with their z-level Talairach 
coordinates) are those displayed in Figure 1 of the main text. 
 
Z=+35
Z=+18 Z=+12 Z=+4
Z=-12
Z=+24
Z=-1
age_sex_ADOSTotal_cov3
Correlation of rCBF with ADOS Total Scores with Excluding ASD Participants Taking Any Psychotropic Medication
N=28
P
-V
al
u
e
s
<0.0001
<0.0001
=0.05
p
o
si
ti
ve
n
e
ga
ti
ve
Figure 34Peterson et al. Supplement
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
54 
 
 
Supplementary Figure S35. Correlation of rCBF with ADOS Total Scores while Covarying for the Use of Any Psychotropic Medication 
This map shows in all slices the statistically significant correlations of ADOS Total scores with rCBF values, while covarying for age and sex, for all 
participants in the ASD group (N=41, 30 males, 11 females, mean age 24.9 years) while covarying for age, sex, and the use of any psychotropic 
medication at the time of MRI scan, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of ADOS Total scores with rCBF values in the ASD group. Highlighted slices 
(with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S36. Correlation of rCBF with SRS Awareness Scores while Excluding ASD Participants Taking Any Psychotropic Medication  
This map shows in all slices the statistically significant correlations of SRS Awareness scores with rCBF values, while covarying for age and sex, in a 
subset of the ASD group (N=25, 19 males, 6 females, mean age 25.1 years) who were not taking any psychotropic medications at the time of the MRI 
scan, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels represent, respectively, significant positive 
or inverse correlations of SRS Awareness scores with rCBF values in the ASD group. Highlighted slices (with their z-level Talairach coordinates) are those 
displayed in Figure 1 of the main text. 
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Supplementary Figure S37. Correlation of rCBF with SRS Awareness Scores while Covarying for the Use of Any Psychotropic Medication 
This map shows in all slices the statistically significant correlations of SRS Awareness scores with rCBF values, while covarying for age and sex, for 
all participants in the ASD group (N=38, 27 males, 11 females, mean age 26.4 years) while covarying for age, sex, and the use of any psychotropic 
medication at the time of MRI scan, displayed at a threshold of P<0.05 after FDR correction for multiple comparisons. Red and blue voxels 
represent, respectively, significant positive or inverse correlations of SRS Awareness scores with rCBF values in the ASD group. Highlighted slices 
(with their z-level Talairach coordinates) are those displayed in Figure 1 of the main text. 
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Supplementary Figure S38. Effects of Diagnosis on rCBF while Covarying for Total Cortical Gray Matter Volume  
This shows the statistically significant differences in rCBF values between the ASD group and TD controls for all slices while covarying for age, 
sex, and total cortical gray matter volume, displayed at a threshold of P<0.05 after correction for multiple comparisons. Voxels in red indicate 
significantly increased rCBF, and blue voxels reduced rCBF, in ASD relative to controls.   
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Supplementary Figure S39. Effects of Diagnosis on rCBF while Covarying for Total White Matter Volume  
This shows the statistically significant differences in rCBF values between the ASD group and TD controls for all slices while covarying for age, 
sex, and total white matter volume, displayed at a threshold of P<0.05 after correction for multiple comparisons. Voxels in red indicate 
significantly increased rCBF, and blue voxels reduced rCBF, in ASD relative to controls. 
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Supplementary Figure S40. Main Effect of Diagnosis Within Different Age Groups 
This shows the statistically significant differences in rCBF values between the ASD group and TD controls while covarying for age and sex, 
separately in youth (≤21 years) and adults (>21 years), displayed at a threshold of P<0.05 after correction for multiple comparisons. Voxels in red 
indicate significantly increased rCBF, and blue voxels reduced rCBF, in ASD relative to controls. 
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Supplementary Figure S41. Correlation of rCBF with ADOS Total Scores Within Different Age Groups 
Red and blue voxels represent, respectively, significant positive or inverse correlations of ADOS total scores with rCBF values separately in youth 
(≤ 21 years) and adults (>21 years) of the ASD group, after FDR correction for multiple comparisons. 
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Supplementary Figure S42. Correlation of rCBF with SRS Awareness Scores Within Different Age Groups 
Red and blue voxels represent, respectively, significant positive or inverse correlations of SRS Awareness scores with rCBF values separately in 
youth (≤ 21 years) and adults (>21 years) of the ASD group, after FDR correction for multiple comparisons. 
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